LHDX - Is Lucira Health a Good Stock to Buy Right Now?
Shares of Lucira Health (NASDAQ: LHDX) exploded out of the gate when the company made its stock market debut in February. Despite an initial run-up, though, this new medical-technology stock has lost nearly half its value since it peaked in February.
Lucira Health's over-the-counter COVID-19 tests racked up millions of dollars in sales during the first three months of 2021, leading some investors to wonder if this beaten-down stock can bounce back. Here's what investors need to know about the road ahead of this medical diagnostics start-up.
Image source: Getty Images.
For further details see:
Is Lucira Health a Good Stock to Buy Right Now?